Brassica Spp.
Generic Name: brassica spp.
Brand Names:
Mustard
Dosage form: SOLUTION. Route: INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS. Active ingredients: BRASSICA RAPA POLLEN (.05 g/mL). Category: BLA.
Overview
Dosage form: SOLUTION. Route: INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS. Active ingredients: BRASSICA RAPA POLLEN (.05 g/mL). Category: BLA.
Dosage
Available as solution for intradermal, percutaneous, subcutaneous use.
Related Medications
Rituximab-arrx
rituximab-arrx
CD20-directed Cytolytic Antibody [EPC]
11 DESCRIPTION Rituximab-arrx is a genetically engineered chimeric murine/human monoclonal IgG1 kappa antibody directed against the CD20 antigen. Rituximab-arrx has an approximate molecular weight of 145 kD. Rituximab-arrx is produced in a mammalian cell (Chinese Hamster Ovary) suspension culture in a nutrient medium. RIABNI (rituximab-arrx) injection is a sterile, preservative-free, clear to slightly opalescent, colorless to slightly yellow solution for intravenous infusion.
Regener-eyes
regener-eyes
Non-Standardized Chemical Allergen [EPC]
Purpose Eye Lubricant
Glatiramer Acetate Injection
glatiramer acetate injection
11 DESCRIPTION Glatiramer acetate, the active ingredient of Glatiramer Acetate Injection, consists of the acetate salts of synthetic polypeptides, containing four naturally occurring amino acids: L-glutamic acid, L-alanine, L-tyrosine, and L-lysine with an average molar fraction of 0.141, 0.427, 0.095, and 0.338, respectively. The average molecular weight of glatiramer acetate is 5,000 – 9,000 daltons. Glatiramer acetate is identified by specific antibodies.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.